Detailed answers about ROKALIN PHARMACEUTICALS LTD, including incorporation, status, business activity, and accounts information.
When was ROKALIN PHARMACEUTICALS LTD founded?
ROKALIN PHARMACEUTICALS LTD was officially incorporated on 22 July 2024 and is registered under company number 15850457. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ROKALIN PHARMACEUTICALS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ROKALIN PHARMACEUTICALS LTD?
ROKALIN PHARMACEUTICALS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ROKALIN PHARMACEUTICALS LTD do?
ROKALIN PHARMACEUTICALS LTD operates in the following sectors: 21200 - Manufacture of pharmaceutical preparations, 71122 - Engineering related scientific and technical consulting activities, 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is ROKALIN PHARMACEUTICALS LTD's registered address?
The registered office address of ROKALIN PHARMACEUTICALS LTD is 15 TERRETT AVENUE, HEADINGTON, OXFORD, OXFORDSHIRE, UNITED KINGDOM, OX3 8FE. This is the official address filed with Companies House for legal and statutory correspondence.
Is ROKALIN PHARMACEUTICALS LTD financially stable?
Financial accounts for ROKALIN PHARMACEUTICALS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.